Breast Reconstruction Market Size, Share, and Demand Analysis by Product Type (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Placement (Dual Plane Insertion, Subglandular Insertion, Submuscular Insertion), End User (Hospitals, Cosmetology Clinics and Ambulatory Surgical Centers) –Forecast to 2030

Market Overview

The global breast reconstruction market size was valued at $584.7 million in 2021, and it will grow at a CAGR of 6.4% during 2021–2030. Moreover, in Europe, the German market contributed the maximum share in 2021, and it is projected to grow at a significant rate of 6.6% during the same period. The key factors contributing to the growth of the market include the increasing awareness about reconstruction procedures, technological advancement, and the rising prevalence of breast cancer, across the world.

The COVID-19 outbreak had a significant impact on hospitals throughout the world, resulting in the collapse of medical services in several areas. Many surgeries were cancelled and surgical procedures were postponed, owing to surgical constraints. It also presented a unique reconstruction of breast issues. In addition, breast implantation was formerly prohibited in many hospitals and cosmetic clinics.

Breast Implants Category Is Highest Revenue Generator in the Market

In 2021, the breast implants category held the largest market share, and it is predicted to increase at a CAGR of 6.6% during 2021–2030. Because of the reduced surgical duration and lack of donor sites, patients usually prefer implants in the breast reconstructing process.

In addition, many women choose reconstruction operations to restore the natural shape of their breasts. This is mostly due to the increase in the frequency of breast reconstruction surgeries and the prevalence of breast cancer in developing nations such as China, India, and South Africa. This helps the market for implants to grow in the coming years. For instance, in China, the market shows a growth rate of around 5.5% during 2021–2022.

Immediate Procedure Is Mostly Preferred by Patients

The immediate procedure includes a quicker recovery, low cost, more natural appearance, and less noticeable scarring. After the removal of the breast, a surgeon initiates the reconstruction process of the breast either with tissue from another location of the body or with an implant. Usually, patients prefer the immediate process after mastectomy, as it allows them to avoid multiple surgeries and less downtime, while eliminating further surgeries in the future. Hence, with the increasing preference for the reconstruction of breasts after mastectomy, the immediate procedure category continues to hold the largest revenue share in the breast reconstruction market.

Moreover, the delayed procedure category is projected to hold the second-largest market share during the forecast period. It is usually favored by patients who are scheduled to receive radiation therapy as part of their adjuvant care and is performed weeks, months, or years later. Although delaying breast reconstruction for several months following radiation therapy may lower the risk of difficulties, patients who have had radiation therapy normally have a higher risk of issues.

Dual Plane Insertion Holds Major Share in the Market

The dual-plane insertion category accounts for the maximum market share, as compared to subglandular insertion and submuscular insertion. This technique assists breast implants to sit in the most natural position and adjusts them to ensure adequate soft-tissue coverage. The placement offers more benefits and fewer complications as compared to a single-pocket location. This allows the breast gland to cover properly the new mound created by the implant under the muscle. The method has a 24-hour recovery time and is less painful.

Moreover, the subglandular insertion category held the second-largest market share in 2021. This is because this method includes no interference with pectoralis muscle function, or movement of the breast that occurs with arm movement if the implant is subpectoral; and no requirement for stretching of muscle for the implant to settle into its final position.

High Prevalence of Breast Cancer Will Drive the Market

Breast cancer is usually detected among women and is treated using mastectomy, in which the entire breast is removed with a surgical process. Breast reconstruction surgeries are used to rebuild the breasts after the removal of natural breasts. Implant reconstruction and autologous or flap reconstruction are the two main techniques used in these surgeries. With the rising prevalence of breast cancer worldwide, women are opting for reconstruction procedures to regain the natural shape of their breasts after the mastectomy.

Moreover, breast cancer is the most commonly diagnosed cancer among women. For instance, as of 2021, breast cancer accounted for 12% of all new annual cancer cases worldwide. Hence, the increasing prevalence of breast cancer, coupled with the growing preference for breast reconstruction procedures, is expected to support the market growth.

North America Leads the Market

North America is expected to lead the overall breast reconstruction market throughout the forecast period, with a revenue share of around 55% in 2030. The surging incidences of breast cancer, increasing breast augmentation procedures, and established healthcare infrastructure are some of the key factors accountable for the largest market share. Also, governments are focusing on the implementation of various programs to spread awareness about the implant procedure, which, in turn, drives the demand for breast reconstruction in North America.

In recent years, the U.S. FDA has approved a large number of products related to implant procedures. For instance, in January 2017, Allergan Plc received the approval from the FDA to commercialize NATRELLE INSPIRA breast implant that offers a new medium firmness gel, or cohesive, implant option for women undergoing breast reconstruction.

Moreover, in Europe, the U.K. accounts for the second-largest market share. Breast enlargement surgery is one of the most regularly performed procedures in the country and involves the insertion of implants under the breast tissue to increase the size or change the shape of the breasts. Furthermore, favorable government policies in the U.K. are expected to increase breast cancer awareness among the population, which, in turn, is likely to drive the market growth in the coming years.

Explore more about this report - Request free sample pages

To Increase Market Share, Companies Involved in Various Strategic Developments

Major players in the breast reconstruction market have been involved in strategic developments, such as the introduction of products, campaigns, and awareness programs, in order to improve their position. For instance:

• In May 2021, GC Aesthetics launched its next-generation breast implants, PERLE, which is a highly innovative line of smooth breast implants that features a proprietary surface technology.
• In October 2021, Sientra Inc. announced the launch of Reshaping Lives: Full Circle, a nationwide program aimed at providing reconstructive breast surgery for post-mastectomy women living in poverty.
• In October 2019, POLYTECH Health and Aesthetics GmbH introduced a new educational social media campaign, which will engage with patients throughout the month for Breast Cancer Awareness.

Key Players in the Market Are:

• Allergan
• GC Aesthetics
• Groupe Sebbin SAS
• Guangzhou Wanhe Plastic Materials Co. Ltd.
• Ideal Implant Incorporated
• Laboratoires Arion
• Mentor Worldwide LLC
• POLYTECH Health and Aesthetics GmbH
• RTI Surgical Holdings
• Shanghai Kangning Medical Device Co. Ltd.
• Sientra Inc.

Market Size Breakdown by Segment

The report offers comprehensive market segmentation analysis along with the estimation for the period 2017–2030.

Based on Product Type

• Breast Implants
• Tissue Expanders
• Acellular Dermal Matrix (ADM)

Based on Procedure

• Immediate
• Delayed
• Revision

Based on Placement

• Dual Plane Insertion
• Subglandular Insertion 
• Submuscular Insertion

Based on End User

• Hospitals
• Cosmetology Clinics and Ambulatory Surgical Centers

Geographical Analysis

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa